Boswellia and Curcumin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Boswellia (indian frankincense) and Curcumin (turmeric). Common drug interactions include oral pain among females and cognitive disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Boswellia and Curcumin. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Boswellia?

Boswellia has active ingredients of indian frankincense. It is often used in arthritis. eHealthMe is studying from 496 Boswellia users. Check the latest studies of Boswellia.

What is Curcumin?

Curcumin has active ingredients of turmeric. It is often used in inflammation. eHealthMe is studying from 3,676 Curcumin users. Check the latest studies of Curcumin.

On Jul, 05, 2026

46 people who take Boswellia and Curcumin together, and have interactions are studied.

Boswellia and Curcumin drug interactions.

What are the common drug interactions of Boswellia and Curcumin, by gender? *:

female:

Oral pain
Orthostatic intolerance (development of symptoms when standing upright which are relieved when sitting back down again)
Osteoporosis (bones weak and more likely to break)
Paradoxical drug reaction
Peripheral swelling
Physical disability
Fatigue (feeling of tiredness)
Anxiety
Pain
Dizziness

male:

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Confusional state
Muscle spasms (muscle contraction)
Pain in extremity
Peripheral swelling
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Skin disorder (skin disease)
Tremor (trembling or shaking movements in one or more parts of your body)
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Cystic fibrosis related diabetes

What are the common drug interactions of Boswellia and Curcumin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Cystic fibrosis related diabetes
Headache (pain in head)

20-29:

Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Injection site pain
Insomnia (sleeplessness)
Night sweats (sweating in night)

30-39:

n/a

40-49:

Fatigue (feeling of tiredness)
Abdominal discomfort
Anxiety
Dizziness
Face injury
Fall
Ligament sprain (ligament stretched)
Loss of consciousness
Memory impairment
Post-traumatic stress disorder

50-59:

Fatigue (feeling of tiredness)
Abscess (pus)
Constipation
Dehydration (dryness resulting from the removal of water)
Drug effect decreased
Haematocrit decreased
Haemoglobin decreased
Headache (pain in head)
Inflammatory pain
Injection site erythema (redness at injection site)

60+:

Alopecia (absence of hair from areas of the body)
Arthralgia (joint pain)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Confusional state
Cough
Deafness
Defaecation urgency (a sudden compelling urge to defecate)
Depression
Dizziness
Drug ineffective

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 30.43%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 14 people, 30.43%
Multiple Myeloma (cancer of the plasma cells): 4 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Boswellia and Curcumin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously